Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy
AbstractCell fusion occurs in development and in physiology and rarely in those settings is it associated with malignancy. However, deliberate fusion of cells and possibly untoward fusion of cells not suitably poised can eventuate in aneuploidy, DNA damage and malignant transformation. How often cell fusion may initiate malignancy is unknown. However, cell fusion could explain the high frequency of cancers in tissues with low underlying rates of cell proliferation and mutation. On the other hand, cell fusion might also engage innate and adaptive immune surveillance, thus helping to eliminate or retard malignancies. Here we consider whether and how cell fusion might weigh on the overall burden of cancer in modern societies. View Full-Text
Share & Cite This Article
Platt, J.L.; Zhou, X.; Lefferts, A.R.; Cascalho, M. Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy. Int. J. Mol. Sci. 2016, 17, 1118.
Platt JL, Zhou X, Lefferts AR, Cascalho M. Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy. International Journal of Molecular Sciences. 2016; 17(7):1118.Chicago/Turabian Style
Platt, Jeffrey L.; Zhou, Xiaofeng; Lefferts, Adam R.; Cascalho, Marilia. 2016. "Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy." Int. J. Mol. Sci. 17, no. 7: 1118.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.